Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

ClinicalTrials.gov ID: NCT00000851

Public ClinicalTrials.gov record NCT00000851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 10:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Trial of Stavudine (d4T) Plus Didanosine (ddI) in Children on Long-Term Stavudine Monotherapy, and Stavudine Versus Stavudine Plus Didanosine in Children on Long-Term Zidovudine Monotherapy: A Rollover Protocol for ACTG 240 Participants and Children Receiving Prescription Zidovudine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and determine the pharmacokinetic disposition of stavudine (d4T) alone and in combination with didanosine (ddI), and whether concurrent administration alters the disposition of either drug. To compare d4T versus d4T plus ddI with respect to short and long term changes from baseline in plasma HIV RNA concentrations. To determine the relationship, if any, between drug exposure and viral burden. In a pilot study of d4T and ddI given to eight children with advanced HIV for 24 weeks, the three children with baseline counts greater than 50 cells/micro liter experienced a 20% increase in their CD4+ lymphocyte counts. Based on these results, controlled trials of the same regimen for children with less advanced HIV disease should be undertaken.

Study identification

NCT ID
NCT00000851
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
198 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Months to 10 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Oct 1998 (Actual)
Last update posted
Nov 4, 2021

Ends 1998

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance California 90502 —
Univ. of Colorado Denver NICHD CRS Aurora Colorado — —
Univ. of Connecticut Health Ctr., Dept. of Ped. Farmington Connecticut 06032 —
Connecticut Children's Med. Ctr. Hartford Connecticut — —
Children's National Med. Ctr., ACTU Washington D.C. District of Columbia 20010 —
Howard Univ. Washington DC NICHD CRS Washington D.C. District of Columbia 20060 —
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209 —
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161 —
Cook County Hosp. Chicago Illinois 60612 —
Chicago Children's CRS Chicago Illinois 60614 —
Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease Chicago Illinois 60637 —
Tulane/LSU Maternal/Child CRS New Orleans Louisiana 70112 —
Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore Maryland 21201 —
HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston Massachusetts 02115 —
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201 —
UMDNJ - Robert Wood Johnson New Brunswick New Jersey 08903 —
NJ Med. School CRS Newark New Jersey — —
SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS Brooklyn New York 11203 —
North Shore-Long Island Jewish Health System, Dept. of Peds. Great Neck New York 11021 —
Schneider Children's Hosp., Div. of Infectious Diseases New Hyde Park New York 11040 —
Metropolitan Hosp. NICHD CRS New York New York 10029 —
Columbia IMPAACT CRS New York New York 10032 —
Incarnation Children's Ctr. New York New York 10032 —
Harlem Hosp. Ctr. NY NICHD CRS New York New York 10037 —
Strong Memorial Hospital Rochester NY NICHD CRS Rochester New York — —
SUNY Stony Brook NICHD CRS Stony Brook New York — —
Bronx-Lebanon Hosp. IMPAACT CRS The Bronx New York 10457 —
DUMC Ped. CRS Durham North Carolina 27710 —
St. Christopher's Hosp. for Children Philadelphia Pennsylvania 19134 —
Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases Charleston South Carolina 29425 —
Children's Med. Ctr. Dallas Dallas Texas 75235 —
Texas Children's Hosp. CRS Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2021 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00000851 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →